Cleared Traditional

K052716 - RAPIRUN H. PYLORI ANTIBODY DETECTION KIT

K052716 is the FDA 510(k) clearance for RAPIRUN H. PYLORI ANTIBODY DETECTION KIT by Otsuka Pharmaceutical Co., Ltd.. It is a Class 1 Microbiology device (product code LYR) cleared through the Traditional 510(k) pathway after a 413-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2006
Decision
413d
Days
Class 1
Risk

K052716 is an FDA 510(k) clearance for the RAPIRUN H. PYLORI ANTIBODY DETECTION KIT. Classified as Helicobacter Pylori (product code LYR), Class I - General Controls.

Submitted by Otsuka Pharmaceutical Co., Ltd. (North Attleboro, US). The FDA issued a Cleared decision on November 16, 2006 after a review of 413 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3110 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Microbiology submissions.

View all Otsuka Pharmaceutical Co., Ltd. devices

Submission Details

510(k) Number K052716 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2005
Decision Date November 16, 2006
Days to Decision 413 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
311d slower than avg
Panel avg: 102d · This submission: 413d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LYR Helicobacter Pylori
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3110
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LYR Helicobacter Pylori

All 45
Devices cleared under the same product code (LYR) and FDA review panel - the closest regulatory comparables to K052716.
H. PYLORI CHEK™
K181400 · Techlab, Inc. · Aug 2018
LIAISON H. pylori IgG, LIAISON H. pylori IgG Control Set
K161139 · DiaSorin, Inc. · Jul 2016
ImmunoCard STAT! HpSA
K153661 · Meridian Bioscience, Inc. · Mar 2016
PREMIER PLATINUM HPSA PLUS, MODELS 601396, 601480
K053335 · Meridian Bioscience, Inc. · Mar 2006
IMMUNOCARDSTAT HPSA
K032222 · Meridian Bioscience, Inc. · Dec 2003
INSTANT-VIEW H. PYLORI ONE STEP RAPID TEST
K024360 · Alfa Scientific Designs, Inc. · Jun 2003